Aegis Ventures is a New York-based venture studio founded in 2020 that co-founds and scales AI-native healthtech startups in partnership. See contact routes.
Aegis Ventures is a New York-based venture studio founded in 2020 that co-founds and scales AI-native healthtech startups in partnership with leading health systems. The firm’s investment thesis targets seed and Series A stages in the artificial intelligence, digital health, and healthtech sectors, primarily within North America, leveraging its Digital Consortium model with 14 regional health systems to identify clinical pain points. Aegis typically leads seed and Series A rounds with check sizes ranging from $1 million to $10 million. Notable portfolio companies include Ascertain (AI workflow automation), Avandra Imaging (real-world imaging data, which raised a $17.5 million Series A), Caregentic (generative AI patient companion), and Optain (AI retinal imaging for disease screening). The firm distinguishes itself through a proprietary platform that combines deep industry insights, aligned capital, and exclusive customer access to accelerate the success rate of new ventures, boasting an 80% seed-to-Series A conversion rate across its five launched companies. While the search results do not cite specific public writing by the firm, its distinctive point
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Aegis Ventures · Full investor directory · Investor access · Company funding database